Photocure ASA (PHO.OL) Financials
PHO.OL Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2025 | 707.1 million | 222.8 million |
| Sept. 30, 2025 | 696.7 million | 210.1 million |
| June 30, 2025 | 685.4 million | 205.6 million |
| March 31, 2025 | 708.6 million | 236.7 million |
PHO.OL Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2025 | 16.2 million | ? |
| Sept. 30, 2025 | 20.8 million | ? |
| June 30, 2025 | -9.9 million | 4.4 million |
| March 31, 2025 | 1.7 million | 4.8 million |
PHO.OL Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| Dec. 31, 2025 | -8.0 million |
| Sept. 30, 2025 | 4.0 million |
| June 30, 2025 | 2.5 million |
| March 31, 2025 | -9.4 million |
PHO.OL Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2025 | 238.9 million | - | - |
| Sept. 30, 2025 | 247.8 million | 11.6 million | 11.6 million |
| June 30, 2025 | 239.1 million | 13.1 million | 13.1 million |
| March 31, 2025 | 259.5 million | - | - |
PHO.OL Shares Outstanding
PHO.OL Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2025 | 13.8 million | -414000 | 103.9 million | - |
| Sept. 30, 2025 | 11.0 million | -862000 | 86.3 million | - |
| June 30, 2025 | 3.1 million | 506000 | 85.4 million | 85.4 million |
| March 31, 2025 | 2.4 million | 1.2 million | 89.7 million | 89.7 million |
PHO.OL Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2025 | 136.7 million | 10.9 million |
| Sept. 30, 2025 | 135.0 million | 19.2 million |
| June 30, 2025 | 135.6 million | 10.0 million |
| March 31, 2025 | 125.3 million | 9.1 million |
PHO.OL
Price: NOK60.60
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.06 NOK
P/E Ratio: -1158.33
Exchange: OSL
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 1.8 billion